Lexeo Therapeutics, Inc. Common Stock(LXEO:US)

Market Cap$195.59M

Key Metrics

Price$2.64

Revenue (TTM)$0

Holders Revenue (TTM)$0

Gross Profit (TTM)-

Earnings (TTM)-$87.5M

EBITDA (TTM)-$88.58M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$71.77M

Total Assets$250.36M

Net Assets$231.5M

Total Debt$7.37M

Lexeo Therapeutics, Inc. Common Stock(LXEO:US)

Market Cap$195.59M

Price history

Key Metrics

Price$2.64

Revenue (TTM)$0

Holders Revenue (TTM)$0

Gross Profit (TTM)-

Earnings (TTM)-$87.5M

EBITDA (TTM)-$88.58M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$71.77M

Total Assets$250.36M

Net Assets$231.5M

Total Debt$7.37M

Financials

NameMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Revenue
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$531K$37K
Cost of Revenue
----------------
Gross Profit
----------------
$22.33M$23.12M$21.65M$30.69M$33.81M$27.38M$31.54M$23.55M$23.29M$14.97M$20.27M$13.98M$19.29M$15.2M$18.01M$15.35M
Research and Development$15.7M$16.21M$15.7M$14.72M$17.17M$18.37M$23.42M$16.56M$15.74M$8.21M$17.25M$11.24M$16.44M$11.39M$15.36M$12.27M
Selling, General, and Administrative$6.63M$6.91M$5.95M$15.97M$16.63M$9.02M$8.12M$6.99M$7.55M$6.76M$3.03M$2.74M$2.85M$3.81M$2.65M$3.08M
Other Operating Expenses----------------
Operating Income
-$22.33M-$23.12M-$21.65M-$30.69M-$33.81M-$27.38M-$31.54M-$23.55M-$23.29M-$14.97M-$20.27M-$13.98M-$19.29M-$15.2M-$17.48M-$15.31M
$2.14M$2.2M$1.37M$4.59M$1.15M$1.46M$2.05M$2.31M$1.61M$787K$165K$534K$633K$622K$427K$168K
Non-Operating Interest Income$2.16M$2.21M$1.46M$1.27M$1.19M$1.49M$2.09M$2.35M$1.65M$1.1M$488K$590K$687K$676K$456K$177K
Non-Operating Interest Expense$17K$25K$82K$59K$40K$30K$35K$35K$37K$50K$52K$53K$50K$54K$29K$9K
Other Income/Expense-$1K$9K-$9K$3.38M-$4K$0-$3K-$1K-$5K-$265K-$271K-$3K-$4K---
Income Before Tax
-$20.2M-$20.92M-$20.28M-$26.1M-$32.66M-$25.92M-$29.49M-$21.24M-$21.68M-$14.19M-$20.11M-$13.44M-$18.66M-$14.58M-$17.06M-$15.14M
Income Tax
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Income
-$20.2M-$20.92M-$20.28M-$26.1M-$32.66M-$25.92M-$29.49M-$21.24M-$21.68M-$14.19M-$20.11M-$13.44M-$18.66M-$14.58M-$17.06M-$15.14M
Minority Interests
----------------
Preferred Stock Dividends
----------------
Net Income to Common
-$20.2M-$20.92M-$20.28M-$26.1M-$32.66M-$25.92M-$29.49M-$21.24M-$21.68M-$14.19M-$20.11M-$13.44M-$18.66M-$14.58M-$17.06M-$15.14M
Shares Outstanding (Basic)
81.18M76.36M60.98M43.57M33.11M-33.06M33M27.98M-25.17M25.17M25.17M-25.17M25.17M
Shares Outstanding (Diluted)
81.18M76.36M60.98M43.57M33.11M-33.06M33M27.98M-25.17M25.17M25.17M-25.17M25.17M
EPS (Basic)
-$0.25-$0.27-$0.33-$0.60-$0.99--$0.89-$0.64-$0.77--$0.80-$0.53-$0.74--$0.68-$0.60
EPS (Diluted)
-$0.25-$0.27-$0.33-$0.60-$0.99--$0.89-$0.64-$0.77--$0.80-$0.53-$0.74--$0.68-$0.60
EBIT
-$20.18M-$20.89M-$20.2M-$26.04M-$32.62M-$25.89M-$29.45M-$21.2M-$21.65M-$14.14M-$20.06M-$13.39M-$18.61M-$14.52M-$17.03M-$15.13M
EBITDA
-$19.63M-$20.36M-$19.67M-$28.92M-$32.12M-$25.37M-$28.95M-$20.71M-$21.17M-$13.39M-$19.32M-$12.94M-$18.16M-$14.08M-$16.68M-$15.13M